XPOF vs CURV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

XPOF

65.5
AI Score
VS
XPOF Wins

CURV

58.2
AI Score

Investment Advisor Scores

XPOF

66score
Recommendation
BUY

CURV

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XPOF CURV Winner
Revenue 4.87M 245.80M CURV
Net Income -4.86M 414,000 CURV
Net Margin -99.9% 0.2% CURV
Operating Income 22.56M 8.56M XPOF
ROE 1.5% -0.2% XPOF
ROA -1.6% 0.1% CURV
Total Assets 309.84M 402.52M CURV
Debt/Equity -1.63 -1.27 XPOF
Current Ratio 0.75 0.79 CURV
Free Cash Flow -26.46M 5.70M CURV

Relative Price Performance (Last 90 Days)

XPOF 1M: -13.9% · 3M: -7.0% CURV 1M: -6.8% · 3M: +63.7%

Current Technical Phase

XPOF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 38.0 · Price: $5.19

CURV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $2.21

Fundamentals Snapshot

Metric XPOF CURV
Market Cap
Forward P/E 7.7 -39.0
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% -0.1%
Gross Margin 0.7% 0.3%
Operating Margin 0.2% 0.0%
EPS -1.48 -0.13
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, XPOF is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.